Fisher Danina
Transaction: 09/29/2026
BUY
Change
+200,000
Price
$0.06
Filing
10/02/2026
Type
BUY
Hepion Pharmaceuticals, Inc.
HEPA • Biotechnology
Strong market move
HEPA+17.53%
vs. previous close $0.10
$0.12
▲ +0.02 (+17.53%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.94M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.02Healthy liquidity · 10.25Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Oct 20, 2026, 12:20 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.12
Change17.53%
Shares Out16.19M
Market Cap$1.94M
Enterprise Value$314.58K
52W Range0.03 - 0.13
Beta1.75
P/E-0.61
P/B1.52
P/FCF-1.22
EV/EBITDA-0.11
EV/FCF-0.20
Price$0.12
Change17.53%
Shares Out16.19M
Market Cap$1.94M
Enterprise Value$314.58K
52W Range0.03 - 0.13
Beta1.75
P/E-0.61
P/B1.52
P/FCF-1.22
EV/EBITDA-0.11
EV/FCF-0.20
Earnings Yield-164.08%
FCF Yield-82.03%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.02
Current Ratio10.25
Quick Ratio10.25
Target$70.00
Target Upside58233.33%
Target Median$70.00
Target Range70.00 - 70.00
Volume5.33K
Avg Volume31.80K
EPS Surprise87.38
Investment DNA
How strong this company looks for long-term investors
48
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.02Healthy liquidity · 10.25Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 3 analyst votes · 2026-10-21
67/100
Neutral
Bullish
1
Hold
2
Bearish
0
Price Target
2026-10-20
Low
$70.00
Mean
$70.00
Median
$70.00
High
$70.00
Insider Transactions
Recent executive and insider activity
Fisher Danina
Transaction: 09/29/2026
BUY
Change
+200,000
Price
$0.05
Filing
10/02/2026
Type
BUY
KI Holdings, Ltd.
Transaction: 08/03/2026
OTHER
Change
+10,000,000
Price
$0.06
Filing
09/16/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Fisher Danina | BUY | +200,000 | $0.06 | 09/29/2026 | 10/02/2026 |
| Fisher Danina | BUY | +200,000 | $0.05 | 09/29/2026 | 10/02/2026 |
| KI Holdings, Ltd. | OTHER | +10,000,000 | $0.06 | 08/03/2026 | 09/16/2026 |
| KI Holdings, Ltd. | OTHER | 0 | Not reported | 08/03/2026 | 09/16/2026 |
| LoPriore Vincent S | BUY | +12,500,000 | $0.06 | 09/03/2026 | 09/14/2026 |
| Purcell Michael J. | BUY | +299,000 | $0.08 | 08/19/2026 | 09/10/2026 |
| Liddy James Gordon | OTHER | 0 | Not reported | 08/19/2026 | 08/21/2026 |
| Stetz Gary S. II | BUY | +299,000 | $0.08 | 08/19/2026 | 08/21/2026 |
| Appajosyula Sireesh | BUY | +1,345,500 | $0.08 | 08/19/2026 | 08/21/2026 |
| Liddy James Gordon | BUY | +299,000 | $0.08 | 08/19/2026 | 08/21/2026 |
| Fisher Danina | BUY | +299,000 | $0.08 | 08/19/2026 | 08/21/2026 |
| LoPriore Chase | BUY | +1,345,500 | $0.08 | 08/19/2026 | 08/21/2026 |
| LoPriore Vincent S | BUY | +1,345,500 | $0.08 | 08/19/2026 | 08/21/2026 |
| Stetz Gary S. | BUY | +1,345,500 | $0.08 | 08/19/2026 | 08/21/2026 |
| LoPriore Vincent S | BUY | +8,000,000 | $0.06 | 08/03/2026 | 08/12/2026 |
| LoPriore Vincent S | BUY | +8,000,000 | $0.05 | 08/03/2026 | 08/12/2026 |
| Appajosyula Sireesh | BUY | +2,000,000 | $0.06 | 08/03/2026 | 08/12/2026 |
| Appajosyula Sireesh | BUY | +2,000,000 | $0.05 | 08/03/2026 | 08/12/2026 |
| Purcell Michael J. | BUY | +2,000,000 | $0.06 | 08/03/2026 | 08/12/2026 |
| Purcell Michael J. | BUY | +2,000,000 | $0.05 | 08/03/2026 | 08/12/2026 |